To test their new drug, the researchers conducted experiments on mice that were fed a high-fat diet, which typically leads to ...

An experimental new treatment is showing early promise in the fight against liver fibrosis—a serious and often silent ...

Biomedical research in liver diseases has traditionally depended on animal models, but ethical concerns and the quest for ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Distinct trends were seen in etiology-based mortality with chronic liver disease (CLD) before, during, and after the COVID-19 ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

Researchers from the Karolinska Institutet in Sweden have found a potential new treatment for non-alcoholic fatty liver ...

The FDA approved ustekinumab-aekn (Selarsdi) injection as an interchangeable biosimilar to Stelara for the treatment of Crohn ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

The patient was admitted to the hospital with right flank pain, ongoing fatigue, and general weakness. Diagnostic tests ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...